This study reports on our experience with whole herpes simplex vaccine
s in Bulgaria for a period of 17 years. More than 1 500 immunized pati
ents with herpes ophtalmicus showed a reduction of the recovery period
, reduced number of the recurrences and reduced risk of visual damage.
More than 14,000 patients suffering from other forms of herpes diseas
es for a longer period showed reduced recovery period and recurrence f
requency in over 95% of the cases. Whole vaccines were well tolerable
with no side effects. This report emphasizes the usefulness of whole h
erpes vaccines.